Full Press Release Details
Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO's 2019 Henri A. Termeer Biotechnology Visionary Award.
RARE
Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO's 2019 Henri A. Termeer Biotechnology Visionary Award
Key Takeaway: Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO's 2019 Henri A. Termeer Biotechnology Visionary Award
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia